Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006-Reference-Cited by-同舟云学术

Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006

Published:2006-09 Issue:5 Volume:25 Page:1240-1248
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Bowman Jennifer,Rousseau Amy,Silk David,Harrison Catherine¹

Affiliation:

1. Avalere Health LLC in Washington, D.C.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference2 articles.

1. ; Medicare Program; Competitive Acquisition of Outpatient Drugs and Biologicals under Part B; Interim Rule,” Federal Register 70 , no. 128 ( 2005 ): 39031 .

2. ; and CMS, “42 CFR Parts 400, 403, 411, 417, and 423 Medicare Program; Medicare Prescription Drug Benefit; Final Rule,” Federal Register 70 , no. 18 ( 2005 ): 4258 .

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two views of cancer medicines: Imagery versus evidence;Health Marketing Quarterly;2022-01-07

2. Generic entry of aromatase inhibitors and pharmaceutical access: Initiation of hormonal therapy, timeliness of initiation, and drug choice;Research in Social and Administrative Pharmacy;2021-09

3. Differences in reimbursement listing of anticancer therapies in China: an observational study;BMJ Open;2020-01

4. Health Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion;American Journal of Health Economics;2019-07

5. Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval;Journal of Managed Care & Specialty Pharmacy;2018-12